S&P 500   3,954.74 (+0.15%)
DOW   32,132.48 (+0.08%)
QQQ   309.16 (-0.19%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
S&P 500   3,954.74 (+0.15%)
DOW   32,132.48 (+0.08%)
QQQ   309.16 (-0.19%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
S&P 500   3,954.74 (+0.15%)
DOW   32,132.48 (+0.08%)
QQQ   309.16 (-0.19%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
S&P 500   3,954.74 (+0.15%)
DOW   32,132.48 (+0.08%)
QQQ   309.16 (-0.19%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
NYSE:ENZ

Enzo Biochem - ENZ Earnings Date, Estimates & Call Transcripts

$2.19
+0.06 (+2.82%)
(As of 03/24/2023 02:15 PM ET)
Add
Compare
Today's Range
$2.11
▼
$2.23
50-Day Range
$1.00
▼
$2.25
52-Week Range
$1.00
▼
$3.06
Volume
369,279 shs
Average Volume
866,177 shs
Market Capitalization
$108.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ENZ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENZ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ENZ Earnings Date and Information

Enzo Biochem has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 8th, 2023 based off prior year's report dates.

Enzo Biochem Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/8/2023
(Estimated)		        
12/12/2022Q1 2023($0.18)($0.18)($0.14)$18.28 million    
10/14/2022Q4 2022($0.17)($0.17)($0.17)$20.28 million
6/9/2022Q3 2022($0.09)($0.09)($0.08)$26.22 million
3/14/2022Q2 2022$0.03+$0.03$0.11$34.05 million    
12/15/2021Q1 2022($0.04)($0.04)($0.03)$26.52 million
10/12/2021Q4 2021$0.07+$0.07$0.07$24.81 million
6/9/2021Q3 2021$0.04+$0.04$0.04$32.80 million
3/15/2021Q2 2021$0.09+$0.09$0.13$31.47 million
12/9/2020Q1 2021$0.01+$0.01$0.01$28.66 million
10/13/2020Q4 2020($0.07)($0.07)($0.07)$19.53 million
6/8/2020Q3 2020($0.17)($0.17)($0.13)$16.90 million
3/5/2020Q2 2020($0.12)($0.12)($0.08)$19.38 million
12/10/2019Q1 2020($0.16)($0.16)($0.16)$20.21 million
10/15/20197/31/2019($0.14)($0.11)+$0.03($0.11)$20.92 million  
6/10/2019Q3($0.15)($0.14)+$0.01($0.75)$19.66 million  
3/11/20191/31/2019($0.13)($0.18)($0.05)($0.18)$19.33 million
12/11/201810/31/2018($0.11)($0.13)($0.02)($0.13)$21.26 million  
10/16/20187/31/2018($0.06)($0.12)($0.06)($0.12)$24.46 million  
6/12/2018Q3 2018($0.02)($0.06)($0.04)($0.06)$25.63 million
3/12/2018Q2 2018($0.01)($0.04)($0.03)($0.06)$27.35 million$26.95 million  
12/7/2017Q1 2018($0.01)($0.01)($0.01)$27.51 million$27.68 million  
3/13/2017Q2 2017($0.04)($0.02)+$0.02($0.02)$26.10 million$26.26 million
12/8/2016Q117($0.05)($0.03)+$0.02($0.03)$25.90 million$26.28 million
10/13/2016Q416($0.06)($0.04)+$0.02($0.85)$26.00 million$26.60 million
6/8/2016Q316($0.06)($0.04)+$0.02($0.03)$24.50 million$18.16 million
3/9/2016Q216($0.06)($0.07)($0.01)($0.29)$24.43 million$24.60 million
12/7/2015Q116($0.05)($0.05)($0.20)$25.00 million$25.18 million
10/13/2015Q415($0.06)($0.06)($0.30)$24.60 million$25.70 million  
6/9/2015Q315($0.06)($0.07)($0.01)($0.08)$24.40 million$23.99 million
3/12/2015Q215($0.09)($0.09)($0.09)$24.20 million$23.09 million
12/9/2014Q114($0.08)($0.08)($0.08)$24.50 million$24.82 million  
10/9/2014Q4 2014($0.07)($0.06)+$0.01($0.05)$23.60 million$24.91 million  
6/9/2014Q314($0.09)($0.05)+$0.04($0.09)$22.80 million$24.00 million
3/11/2014Q2 2014($0.09)($0.09)($0.09)$22.00 million$22.93 million  
12/10/2013Q1 2014($0.07)($0.07)($0.07)$24.13 million  
10/15/2013Q4 2013($0.08)($0.08)($0.08)$22.00 million$23.30 million  
6/10/2013Q3 2013($0.15)($0.15)($0.15)$22.20 million$22.60 million  
3/12/2013Q2 2013($0.06)($0.14)($0.08)($0.14)$25.02 million$22.21 million
12/10/2012Q1 2013($0.06)($0.09)($0.03)($0.09)
10/15/2012Q4 2012($0.07)($0.11)($0.04)$0.47
6/11/2012Q3 2012($0.07)($0.09)($0.02)($0.09)
3/12/2012Q2 2012($0.09)($0.11)($0.02)($0.11)
12/12/2011Q1 2012($0.07)($0.12)($0.05)($0.12)
10/14/2011Q4 2011($0.09)($0.11)($0.02)($0.11)
6/9/2011Q3 2011($0.10)($0.05)+$0.05($0.05)
3/14/2011Q2 2011($0.10)($0.15)($0.05)($0.15)
12/13/2010Q1 2011($0.08)($0.03)+$0.05($0.03)
10/14/2010Q4 2010($0.10)($0.10)($0.05)
6/9/2010Q3 2010($0.08)($0.12)($0.04)($0.12)
3/12/2010Q2 2010($0.08)($0.27)($0.19)($0.27)
12/10/2009Q1 2010($0.10)($0.05)+$0.05($0.05)
10/14/2009Q4 2009($0.05)($0.14)($0.09)($0.14)
6/15/2009Q3 2009($0.08)($0.08)($0.05)
3/12/2009Q2 2009($0.21)($0.21)($0.21)
12/10/2008Q1 2009($0.04)($0.17)($0.13)($0.17)
10/14/2008Q4 2008($0.06)($0.09)($0.03)($0.09)
6/9/2008Q3 2008($0.07)($0.06)+$0.01($0.06)
3/11/2008Q2 2008($0.12)($0.11)+$0.01($0.11)












Enzo Biochem Earnings - Frequently Asked Questions

When is Enzo Biochem's earnings date?

Enzo Biochem has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 8th, 2023 based off last year's report dates. Learn more on ENZ's earnings history.

How much revenue does Enzo Biochem generate each year?

Enzo Biochem (NYSE:ENZ) has a recorded annual revenue of $107.07 million.

How much profit does Enzo Biochem generate each year?

Enzo Biochem (NYSE:ENZ) has a recorded net income of -$18.26 million. ENZ has generated -$0.72 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NYSE:ENZ) was last updated on 3/24/2023 by MarketBeat.com Staff